Stocks in Spotlight: CommonWealth REIT, Arena Pharmaceuticals, SPDR S&P Homebuilders, Keryx Biopharmaceuticals

Lakeway, TX -- (SBWIRE) -- 03/08/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

CommonWealth REIT(NYSE:CWH) is lower 1.72% and is trading at $21.72. CommonWealth REIT (CWH) is a real estate investment trust (REIT). CWH’s primary business is the ownership and operation of real estate, including office and industrial buildings and leased industrial land. As of December 31, 2011, the Company owned 516 properties. Its portfolio includes 317 office properties with 40.0 million square feet and 199 industrial and other properties with 32.3 million square feet.

How Should Investors Trade CWH After The Recent Movement? Find Out Here

Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) is lower 0.82% and is trading at $8.46. Arena Pharmaceuticals, Inc. (Arena) is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors (GPCRs), in four therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. After completing various studies, analyses and other activities in response to the lorcaserin CRL, in December 2011, the Company resubmitted the lorcaserin NDA.

Is ARNA Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here

SPDR S&P Homebuilders (ETF)(NYSEARCA:XHB) moved down 0.27% and is trading at $29.19. SPDR S&P Homebuilders ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Homebuilders Select Industry Index. The S&P Homebuilders Select Industry Index represents the homebuilding sub-industry portion of the S&P Total Markets Index.

Is XHB a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here

Keryx Biopharmaceuticals(NASDAQ:KERX) is lower 2.00% and is trading at $7.26. Keryx Biopharmaceuticals, Inc. (Keryx) is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and renal disease.

How Should Investors Trade KERX After The Latest Earnings Report? Find Out Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.